The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CYTOKINETICS INC COM NEW 23282W605 9,851 875,656 SH   SOLE   875,656 0 0
IMMUNOMEDICS INC COM 452907108 60,656 4,373,178 SH   SOLE   4,373,178 0 0
BIOHAVEN PHARMACTL HLDG CO L COM G11196105 92,446 2,111,111 SH   SOLE   2,111,111 0 0
SUNESIS PHARMACEUTICALS INC COM PAR 867328700 95 129,517 SH   SOLE   129,517 0 0